Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
3.460
-0.030 (-0.86%)
At close: Aug 7, 2025, 4:00 PM
3.700
+0.240 (6.94%)
Pre-market: Aug 8, 2025, 8:40 AM EDT

Atea Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202019 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2020
----351.3748.63
Upgrade
Revenue Growth (YoY)
----622.49%-
Upgrade
Cost of Revenue
54.1883.3770.6162.39167.2138.02
Upgrade
Gross Profit
-54.18-83.37-70.61-62.39184.1610.61
Upgrade
Selling, General & Admin
42.9348.8549.9248.7145.7921.64
Upgrade
Operating Expenses
53.1948.8549.9248.7145.7921.64
Upgrade
Operating Income
-107.37-132.22-120.53-111.1138.38-11.03
Upgrade
Interest & Investment Income
11.9925.4929.2211.150.210.08
Upgrade
EBT Excluding Unusual Items
-86.02-106.73-91.31-99.95138.59-10.95
Upgrade
Other Unusual Items
-49.25-60.73-43.63-19.55--
Upgrade
Pretax Income
-135.27-167.46-134.94-119.5138.59-10.95
Upgrade
Income Tax Expense
0.860.931.02-3.5917.4-
Upgrade
Net Income
-136.13-168.39-135.96-115.91121.19-10.95
Upgrade
Net Income to Common
-136.13-168.39-135.96-115.91121.19-10.95
Upgrade
Shares Outstanding (Basic)
848483838322
Upgrade
Shares Outstanding (Diluted)
848483838822
Upgrade
Shares Change (YoY)
0.83%1.05%0.17%-5.67%308.70%113.98%
Upgrade
EPS (Basic)
-1.61-2.00-1.63-1.391.46-0.51
Upgrade
EPS (Diluted)
-1.62-2.00-1.63-1.391.37-0.51
Upgrade
Free Cash Flow
-116.87-135.5-85.4-122.93-87.01296.71
Upgrade
Free Cash Flow Per Share
-1.38-1.61-1.02-1.48-0.9913.74
Upgrade
Gross Margin
----52.41%21.82%
Upgrade
Operating Margin
----39.38%-22.68%
Upgrade
Profit Margin
----34.49%-22.51%
Upgrade
Free Cash Flow Margin
-----24.76%610.10%
Upgrade
EBITDA
-106.95-131.8-120.11-110.84138.41-11.01
Upgrade
EBITDA Margin
----39.39%-22.64%
Upgrade
D&A For EBITDA
0.420.420.420.260.030.02
Upgrade
EBIT
-107.37-132.22-120.53-111.1138.38-11.03
Upgrade
EBIT Margin
----39.38%-22.68%
Upgrade
Effective Tax Rate
----12.55%-
Upgrade
Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q